New Zealand records 13 more positive COVID-19 cases on quarantined boat

Article content

WELLINGTON — New Zealand said on Tuesday that 13 more crew members of a fishing boat quarantined in the capital city of Wellington have tested positive for COVID-19.

Two crew members of the Viking Bay, a Spanish-flagged deep sea fishing vessel that arrived in New Zealand last week, had previously been reported as confirmed with the virus.

All 15 affected crew have now been transferred to an onshore quarantine facility in Wellington, New Zealand’s health ministry said in a statement.

One of the crew was confirmed last week to have the Delta variant. No link has been shown between this case and any other cases previously identified in New Zealand. Genome sequencing of the 13 positive test results will begin on Tuesday.

New Zealand has largely eliminated coronavirus from the community with the last recorded positive COVID-19 case reported in February. It has so far recorded about 2,500 cases and 26 deaths from the virus. (Reporting by Praveen Menon; Editing by Muralikumar Anantharaman)

Source link


How To Use Instagram To Promote Writers

Instagram has given birth to plenty of careers in recent times. Even small businesses and large brands utilize Instagram as a marketing tool. Visualization...

The best investment of all: The people you love the most

In early 2013, three years after the unexpected death of her husband, Chanel Reynolds posted a warning to those who had neglected the...

2021 best new TV shows to watch, stream, obsess about

CNET editors pick the products and services we write about. When you buy through our links, we may get a commission. ...

Inside Business Insider’s Story About a Failed American Tech Dream

What's wrong with this picture? A software engineer spent 8 hours daily applying to entry-level coding jobs for 6 months. She was rejected...

U.S. FDA declines to approve Avenue’s IV formulation of painkiller

Article content Avenue Therapeutics Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve its intravenous formulation of painkiller...